Deep Track Capital, LP - 05 Feb 2026 SCHEDULE 13G Report for Ocular Therapeutix, Inc Common Stock, $0.0001 par value per share (OCUL)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Ocular Therapeutix, Inc Common Stock, $0.0001 par value per share
Symbol
OCUL
Shares outstanding
218,988,928 shares
Disclosed Ownership
11,234,132 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 16:38:25 UTC
Date of event
05 Feb 2026
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.1% 11,234,132 0 0 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.1% 11,234,132 0 11,234,132 /s/ David Kroin David Kroin, Director
David Kroin 5.1% 11,234,132 0 11,234,132 /s/ David Kroin David Kroin